U.S. Health and Human Services Secretary Robert F. Kennedy Jr. announced a bold plan to identify the cause of autism by September 2025. Speaking at a cabinet meeting with President Donald Trump, Kennedy declared a global research initiative involving hundreds of scientists to determine the source of rising autism rates, which reached 1 in 36 children by 2020, according to the CDC.
“We’ll know by September what has caused the autism epidemic and how to eliminate those exposures,” Kennedy said, hinting at environmental and artificial factors. The initiative is part of Trump’s broader “Make America Healthy Again” Commission, which is also reviewing rising childhood conditions like asthma and ADHD.
The autism community, however, responded with skepticism. Kristyn Roth of the Autism Society of America criticized the deadline and the framing of autism as an “epidemic,” warning it promotes fear and stigmatization. Experts caution that increased diagnoses are largely due to expanded diagnostic criteria and awareness, not an unknown epidemic.
Kennedy, known for promoting a disproven link between vaccines and autism, confirmed vaccines will be reviewed, along with potential environmental and lifestyle triggers. Meanwhile, a recent study has strengthened ties between prenatal diabetes and autism risk.
Controversy deepened after reports surfaced of David Geier—previously fined for unlicensed medical practices—being hired to investigate vaccine links. Lawmakers and advocacy groups fear the spread of misinformation under Kennedy’s leadership.
The National Institutes of Health and the CDC, both under Kennedy’s purview, are planning multimillion-dollar research efforts into autism causes, including vaccine-related studies. Critics argue the push may politicize science and mislead the public.
Despite widespread concern, Kennedy remains firm: “There will be no bigger news than finding the cause of autism.” Whether science can meet his deadline remains uncertain.


Trump Signs Executive Order Threatening 25% Tariffs on Countries Trading With Iran
India–U.S. Interim Trade Pact Cuts Auto Tariffs but Leaves Tesla Out
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
NASA Partners with Katalyst to Save Swift Observatory with Innovative Docking Mission
Is space worth the cost? Accounting experts say its value can’t be found in spreadsheets
Federal Appeals Court Blocks Trump-Era Hospital Drug Rebate Plan
Trump Says “Very Good Talks” Underway on Russia-Ukraine War as Peace Efforts Continue
Novo Nordisk Launches Once-Daily Wegovy Pill in U.S. at Competitive Pricing
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
Trump Allows Commercial Fishing in Protected New England Waters
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
Netanyahu to Meet Trump in Washington as Iran Nuclear Talks Intensify
Lost in space: MethaneSat failed just as NZ was to take over mission control – here’s what we need to know now
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s
Jack Lang Resigns as Head of Arab World Institute Amid Epstein Controversy
US Pushes Ukraine-Russia Peace Talks Before Summer Amid Escalating Attacks
Tabletop particle accelerator could transform medicine and materials science 



